US Patent Issued to JANUX THERAPEUTICS on April 21 for "Inhibitory T cell receptor peptides and discovery methods" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,816, issued on April 21, was assigned to JANUX THERAPEUTICS INC. (La Jolla, Calif.).

"Inhibitory T cell receptor peptides and discovery methods" was invented by David Campbell (La Jolla, Calif.), Ramesh Bhatt (La Jolla, Calif.) and Thomas Diraimondo (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods of inhibiting an interaction of a T cell receptor with a peptide-major histocompatibility complex comprising administering inhibitory peptides that bind to the T cell receptor without the aid of a major histocompatibility complex to inhibit the interaction, and methods of identifying the inhibitory peptides." ...